SIGNPATH PHARMA, INC. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b4869b86-4e04-43b2-8f78-79db3689dc1a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-1.6M | 2015-01-01 – 2015-12-31 | evidence 0001493152-16-008758 |
| FY 2014 | $-2.7M | 2014-01-01 – 2014-12-31 | evidence 0001096906-15-000373 |
| FY 2013 | $-10.9M | 2006-05-15 – 2014-03-31 | evidence 0001096906-14-000659 |
| FY 2012 | $-9.5M | 2006-05-15 – 2013-03-31 | evidence 0001096906-13-000787 |
| FY 2011 | $-7.7M | 2006-05-15 – 2012-03-31 | evidence 0001096906-12-001533 |
| FY 2010 | $-2.1M | 2010-01-01 – 2010-12-31 | evidence 0001096906-12-000735 |
| FY 2009 | $-730.7k | 2009-01-01 – 2009-12-31 | evidence 0001096906-12-000735 |
| FY 2008 | $-1.7M | 2008-01-01 – 2008-12-31 | evidence 0001096906-12-000735 |
| FY 2007 | $-526.8k | 2007-01-01 – 2007-12-31 | evidence 0001096906-12-000735 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).